APA (7th ed.) Citation

Oakes, T. M. M., Skljarevski, V., Zhang, Q., Kielbasa, W., Hodsdon, M. E., Detke, H. C., . . . Saper, J. R. (2018). Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study. Cephalalgia, 38(6), 1015-1025. https://doi.org/10.1177/0333102417747230

Chicago Style (17th ed.) Citation

Oakes, Tina Marie Myers, Vladimir Skljarevski, Qi Zhang, William Kielbasa, Michael E. Hodsdon, Holland C. Detke, Angelo Camporeale, and Joel R. Saper. "Safety of Galcanezumab in Patients with Episodic Migraine: A Randomized Placebo-controlled Dose-ranging Phase 2b Study." Cephalalgia 38, no. 6 (2018): 1015-1025. https://doi.org/10.1177/0333102417747230.

MLA (9th ed.) Citation

Oakes, Tina Marie Myers, et al. "Safety of Galcanezumab in Patients with Episodic Migraine: A Randomized Placebo-controlled Dose-ranging Phase 2b Study." Cephalalgia, vol. 38, no. 6, 2018, pp. 1015-1025, https://doi.org/10.1177/0333102417747230.